Trim JPM 40-50% to below benchmark weight on stretched valuation with mechanical re-entry triggers
Underweight rating is a deliberate departure from the 8/21 lesson's elevated bar, justified by (a) four stacked caution signals not present on 8/21 (stretched forward P/E 25% above average, MACD negative for 14 sessions, ATR compression at 5.89, two binary catalysts with downside skew), (b) the 9/1 reflection's guidance to tighten the deferral gate after sequential Hold alpha bleed of approximately -2.0% across 8/25-8/31, and (c) two binary catalysts within six weeks (FOMC Sept 17, Q3 earnings mid-October). The $325 trader rebuy target is rejected as multi-stage market timing, not value discipline. If price breaks above $358 with volume and MACD confirmation before any drawdown, the framework reverts to Hold or Overweight per Tranche A trigger — discipline is asymmetric in execution but not in conviction.
| Position | Action |
|---|---|
| Current JPM holding | Trim 40-50% to bring position weight below benchmark |
| Residual position below $329 | Hard stop — exit residual position |
| Decisive break below $350.37 | No averaging down; triggers full thesis reassessment |
JPM is one of the highest-quality financial franchises in the world, with accelerating earnings, diversified growth engines, a fortress balance sheet, and substantial capital-return capacity. It is not a deep-value stock, but at approximately 14.24x forward earnings, it appears reasonably priced for a bank generating a 17.79% ROE, approximately 7% forward EPS growth, and more than $45B of annualized capital returns.
| Indicator | Value | Signal |
|---|---|---|
| Close | $356.22 | neutral |
| 10 EMA | $356.10 | neutral |
| 50 SMA | $348.02 | bullish |
| 200 SMA | $315.43 | bullish |
| RSI (14) | 53.58 | neutral |
| MACD | 1.98 | bearish |
| MACD Signal | 3.24 | bearish |
| MACD Histogram | -1.26 | bullish |
| ATR (14) | $5.89 | neutral |
| Bollinger Middle Band | $358.08 | neutral |
| Bollinger Upper Band | $365.79 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close below $350.37 on volume >7M with renewed MACD deterioration
Then: Target $335-340 first; triggers full thesis reassessment, likely confirms Underweight
Balance sheet scaling with strong asset growth and capital generation
EV: $365.18–$365.79 · concedes: JPM is not cheap; 15.25x trailing P/E and 2.68x price-to-book are not bargain multiples; Near-term momentum is mixed with MACD below signal line; Q2 included an estimated $4.4B unusual item; Rising G-SIB buffers can reduce excess capital and moderate future repurchases; Higher rates can pressure borrowers, duration, funding, and market valuations; SG&A increased approximately 12.3% YoY; Credit performance in CRE, cards, and consumer lending needs monitoring; Succession is a genuine governance risk
JPM at $356 is a sell or avoid because Q2 2026 earnings were inflated by a $4.4B one-time gain masking underlying weakness, the rate environment has finite shelf life, buyback capacity has hit a structural ceiling, and technicals show negative momentum at resistance with asymmetric downside risk.
· concedes: The Q2 print did show some underlying strength; Jamie Dimon remains an exceptional operator; The fortress balance sheet remains a genuine asset; The rate environment has been constructive in the near term
→ vs conservative: The conservative analyst's 'don't fight the trend' argument ignores that trends end at extremes; 12.9% above the 200 SMA with MACD negative for 14 sessions is exhaustion, not continuation signal
→ vs conservative: Holding at $356 with only 2.7% upside to resistance but 11.5% downside to the 200 SMA is a negative expected value position; JPM at $356 is not a 'savings bond' and the stretched P/E of 14.24x (25% above average) is not 'reasonable'
→ vs conservative: The G-SIB buffer headwind and CEO succession risk are dismissed as 'known' or 'background noise,' but known risks and priced risks are not synonymous; regulatory drag is historically underpriced until it hits the capital plan
→ vs conservative: The credit risk dismissal ignores a $1.52 trillion loan book with CRE and card delinquencies at current levels; a 50 bps reserve build wipes out a quarter of buyback support
→ vs neutral: The ATR compression thesis that it 'could resolve in either direction' is intellectually lazy; when volatility compresses 27% below peak at multi-month highs with negative MACD momentum, historical resolution skews toward mean reversion, not breakout
→ vs neutral: The August breakout above $365.18 came on declining volume and lacks the 7 million share volume confirmation needed to sustain the move; that absence is information
→ vs neutral: Waiting for confirmation of breakdown at $350.37 means giving up eight points of premium; the time to sell is while the trend still supports prices, not after it breaks
| Bollinger Lower Band | $350.37 | bullish |
| Volume | 5,336,079 | neutral |
Support: 354.12 · 353.79 · 350.37 · 348.02 · 344.71 | Resistance: 358.08 · 361.47 · 365.18 · 365.79
JPM is in a coiled-spring technical configuration with price sitting essentially on the 10 EMA at $356.22, ATR compressing to $5.89 (down 27% from July peak), and MACD histogram contracting from -1.92 to -1.26 over 8 sessions. The long-term uptrend is firmly intact with price 12.9% above the 200 SMA, but near-term momentum is bearish with MACD below signal. Support sits at $350.37 (Bollinger lower band confluence with 1× ATR stop), while resistance is at $358.08 (Bollinger middle). The recommendation is to HOLD existing longs and wait for a close above $358.08 with contracting MACD histogram as the entry trigger, with stops at the 50 SMA ($348.02).
Market Cap
$946.9B
PE Ratio (TTM)
15.25x
Forward PE
14.24x
PEG Ratio
1.65
Price/Book
2.68x
EPS (TTM)
$23.36
Forward EPS
$25.01
Dividend Yield
1.69%
Beta
0.977
52-Week Range
$279.10 – $366.50
50-Day MA
$348.29
200-Day MA
$317.52
Net Income (TTM)
$63.63B
Revenue (TTM)
$186.33B
Profit Margin
34.9%
Operating Margin
50.4%
ROE
17.79%
ROA
1.36%
Tangible Book Value/Share
~$107
Q2 2026 Revenue
$52.85B
Q2 2026 Net Income
$21.16B
Q2 2026 Diluted EPS
$7.70
Q2 2026 Net Interest Income
$25.51B
Q1 2026 Revenue
$49.83B
Q1 2026 Net Income
$16.49B
Q1 2026 Diluted EPS
$5.94
Q1 2026 Net Interest Income
$25.37B
Q4 2025 Revenue
$45.80B
Q4 2025 Net Income
$13.03B
Q4 2025 Diluted EPS
$4.63
Q4 2025 Net Interest Income
$24.99B
Q3 2025 Revenue
$46.43B
Q3 2025 Net Income
$14.39B
Q3 2025 Diluted EPS
$5.07
Q3 2025 Net Interest Income
$23.97B
Q2 2025 Revenue
$44.88B
Q2 2025 Net Income
$14.99B
Q2 2025 Diluted EPS
$5.24
Q2 2025 Net Interest Income
$23.21B
Q2 2026 Total Assets
$5.02T
Q2 2026 Total Loans (Net)
$1.52T
Q2 2026 Total Equity
$374.6B
Q2 2026 Tangible Book Value
$289.3B
Q2 2026 Total Debt
$532.95B
Q2 2026 Cash & Equivalents
$309.8B
Q2 2026 Trading Securities
$794.2B
Q2 2026 HTM Securities
$268.5B
Q2 2026 Common Equity
$353.6B
Q2 2026 Preferred Equity
$21.04B
Q2 2026 Diluted Shares
2.694B
CET1 Estimate
~15-16%
Q2 2026 Operating Cash Flow
-$25.28B
Q2 2026 Investing Cash Flow
$6.39B
Q2 2026 Financing Cash Flow
$18.80B
Q2 2026 Dividends Paid
$4.34B
Q2 2026 Buybacks
$6.79B
Q2 2026 Preferred Stock Issued
$3.00B
Q2 2026 Preferred Stock Repaid
$2.00B
Annualized Buyback Pace
~$30B+ per year
Annualized Dividend
~$17B
Annual Capital Return
$45B+
Strengths
Concerns
The fundamentals section reveals JPMorgan Chase as the gold standard of global banking, delivering record-level earnings with $63.63B in TTM net income and 17.79% ROE—exceptional for an institution of its scale. The bank operates a fortress balance sheet with $5.02T in assets and estimated CET1 of 15-16%, while aggressively returning ~$45B+ annually to shareholders via dividends and buybacks. Q2 2026 was a watershed quarter with revenue up 17.8% YoY and NII expansion of 9.9%, though the report notes a ~$4.4B unusual item in net income and highlights key risks including credit normalization, NIM compression from rate cuts, and regulatory pressures on capital return capacity.
Macro: Interest rate regime is the dominant variable: 10-Year UST yield at ~4.8% (per GuruFocus, Sept 2), Polymarket pricing 89% probability of no Fed cuts in 2026, 42% probability of at least one Fed hike in 2026, and 0% probability of 6+ cuts. The 'no hikes' probability fell 15pp week-over-week, shifting from 'no cuts, no hikes' to 'no cuts, possibly hikes' — a mildly hawkish shift that is the single most important macro driver for JPM. Recession odds remain benign: US 8% (-1pp WoW), UK 8%, Japan 7% (-13.5pp WoW).